Michael Sneller, MD, Infectious Disease, Bethesda, MD

MichaelCharlesSnellerMD

Infectious Disease Bethesda, MD

Physician

Are you Dr. Sneller?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 56 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

  • Office

    National Institutes Of Health
    10 Center Drive Msc 1876
    Bethesda, MD 20892
    Phone(301) 496-0491
    Fax(301) 496-0491
  • Is this information wrong?

Summary

  • Dr. Michael Sneller, MD is an infectious disease specialist in Bethesda, Maryland. He is currently licensed to practice medicine in Maryland and North Carolina.

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFELLOWSHIP
  • Duke University Hospital
    Duke University HospitalRESIDENCY
  • University of Kansas School of Medicine
    University of Kansas School of MedicineMEDICAL_SCHOOL

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1985 - 2021
  • NC State Medical License
    NC State Medical License 1982 - 1998
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Study Shows Health of Ebola Survivors in Liberia Has Improved: One-Year Results from Partnership for Research on Ebola Virus in Liberia (PREVAIL) 3 Published in the New England Journal of Medicine
    Study Shows Health of Ebola Survivors in Liberia Has Improved: One-Year Results from Partnership for Research on Ebola Virus in Liberia (PREVAIL) 3 Published in the New England Journal of MedicineMarch 07, 2019
  • Ebola Survivors in Liberia Face Ongoing Health Issues, Study Finds
    Ebola Survivors in Liberia Face Ongoing Health Issues, Study FindsMarch 07, 2019
  • NIH Launches Study to Test Combination Antibody Treatment for HIV Infection
    NIH Launches Study to Test Combination Antibody Treatment for HIV InfectionSeptember 20, 2018
  • Join now to see all

Grant Support

  • Clinical, Immunopathogenic And Therapeutic Studies Of SyNational Institute Of Allergy And Infectious Diseases2002–2004
  • Clinical/Immunopathogenic/Therapeutic Studies:VasculitisNational Institute Of Allergy And Infectious Diseases2001
  • Clinical, Immunopathogenic And Therapeutic Studies Of Systemic VasculitisNational Institute Of Allergy And Infectious Diseases2000
  • Clinical, Immunopathogenic And Therapeutic Studies Of Systemic Vasculitis And ..National Institute Of Allergy And Infectious Diseases1998–1999
  • Clinical, Immunopathogenic, Therapeutic Studies Of Vasculitis And Other DiseasesNational Institute Of Allergy And Infectious Diseases1993–1997
  • Studies Of Primary Immunodeficiency DiseasesNational Institute Of Allergy And Infectious Diseases1990–1992